Cellcura ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cellcura ASA Updates on Private Placement and Subsequent Offering
Cellcura ASA announced that the Financial Supervisory Authority of Norway has approved the Company's prospectus regarding listing on Oslo Axess of 9,136,632 new shares in CellCura issued in connection with a private placement of shares, tranche 1, completed on October 24, 2012 at a subscription price per share of NOK 0.46; private placement, tranche 2, of up to 34,341,626 new shares at a subscription price of NOK 0.46 per share; and subsequent offering of up to 10,869,565 offer shares at a price of NOK 0.46 per share. The Company also announced that offer shares in subsequent offering may be subscribed for by shareholders that owned shares in the Company as of October 24, 2012 and who were not offered to participate in private placement. The holders of subscription rights will be entitled to subscribe for and be allocated one offer share for every subscription right the eligible shareholder is position of in the subsequent offering. The shares not subscribed for by the eligible shareholders may be subscribed for by the public. The subscription price is NOK 0.46 per share. The subscription period is from November 13, 2012 to November 28, 2012 at 16:00 (CET). It is expected that payment for subscribed shares will be made on December 4, 2012. Trading in issued shares is expected to commence on or about December 11, 2012. The shares will be delivered through the facilities of the VPS. The Manager is VL Corporate.
- Share this
- Digg this